ProfileGDS4718 / 226132_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 41% 42% 42% 49% 67% 75% 46% 42% 51% 56% 35% 74% 50% 58% 56% 58% 58% 60% 40% 46% 55% 57% 52% 53% 70% 53% 60% 50% 62% 64% 71% 38% 45% 72% 64% 67% 48% 47% 48% 51% 71% 62% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.654352
GSM549102patient 115, normal, homogenized [OPG study]5.070941
GSM549104patient 119, normal, homogenized [OPG study]5.0714142
GSM549108patient 138, normal, homogenized [OPG study]5.1336542
GSM549119patient 077, normal, homogenized [OPG study]5.4677749
GSM549133patient 032, cancer, homogenized [OPG study]6.6212567
GSM549139patient 042, cancer, homogenized [OPG study]7.349475
GSM549099patient 107, normal, homogenized [OPG study]5.301346
GSM549109patient 139, normal, homogenized [OPG study]5.1209642
GSM549110patient 046, normal, homogenized [OPG study]5.5573551
GSM549114patient 063, normal, homogenized [OPG study]5.8365556
GSM549122patient 082, normal, homogenized [OPG study]4.7620835
GSM549134patient 033, cancer, homogenized [OPG study]7.2826874
GSM549136patient 036, cancer, homogenized [OPG study]5.46950
GSM549140patient 044, cancer, homogenized [OPG study]5.9944158
GSM549111patient 047, normal, homogenized [OPG study]5.872956
GSM549113patient 057, normal, homogenized [OPG study]5.9475258
GSM549132patient 031, cancer, homogenized [OPG study]5.961558
GSM549137patient 038, cancer, homogenized [OPG study]6.1160260
GSM549142patient 047, cancer, homogenized [OPG study]5.1407740
GSM549100patient 110, normal, homogenized [OPG study]5.3016446
GSM549107patient 135, normal, homogenized [OPG study]5.7768755
GSM549115patient 068, normal, homogenized [OPG study]5.8903357
GSM549116patient 072, normal, homogenized [OPG study]5.6119752
GSM549120patient 078, normal, homogenized [OPG study]5.6600853
GSM549131patient 030, cancer, homogenized [OPG study]6.9751370
GSM549118patient 074, normal, homogenized [OPG study]5.6636153
GSM549129patient 027, cancer, homogenized [OPG study]6.15860
GSM549123patient 088, normal, homogenized [OPG study]5.4771750
GSM549124patient 006, cancer, homogenized [OPG study]6.2632962
GSM549126patient 015, cancer, homogenized [OPG study]6.3763164
GSM549128patient 025, cancer, homogenized [OPG study]6.9985871
GSM549103patient 117, normal, homogenized [OPG study]4.9705238
GSM549117patient 073, normal, homogenized [OPG study]5.2032245
GSM549138patient 041, cancer, homogenized [OPG study]7.1192472
GSM549141patient 045, cancer, homogenized [OPG study]6.4591364
GSM549130patient 028, cancer, homogenized [OPG study]6.6300767
GSM549101patient 111, normal, homogenized [OPG study]5.4194948
GSM549105patient 128, normal, homogenized [OPG study]5.3759247
GSM549106patient 134, normal, homogenized [OPG study]5.35148
GSM549112patient 048, normal, homogenized [OPG study]5.53851
GSM549125patient 011, cancer, homogenized [OPG study]6.9595271
GSM549127patient 024, cancer, homogenized [OPG study]6.3486662
GSM549135patient 035, cancer, homogenized [OPG study]8.0659781